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INTRODUCTION:
Trachoma is a form of kerato-conjunctivitis, with a 
world wide distribution, and, on account of its potentialities for 
causing severe visual impairment and even blindness, is generally 
regarded as the most important ocular disease. It has been 
recognized as such from earliest times, and discussion as to its 
causation, pathology, clinical effects and treatment has occupied 
a large section of ophthalmic literature throughout the ages, but 
many problems associated with it remain to be elucidated. Recent
work has advanced our knowledge of its aetiology (T’ang, Chang,
1 cLHuang, and Wang,* Collier, Duke-Elder, and Jones *), but much
controversy still exists concerning diagnosis, treatment and control.
It is now conceded by most authorities that the causative agent is
the Chlamydozoon trachomatis, one of the larger-sized viruses, and
now that this has been successfully cultivated in quantity the way
may be open to the eventual production of a prophylactic and curative
vaccine, but at present our most effective therapeutic agents are the
sulphonamides and the antibiotics.
I first became interested in this disease during the 
Second World War, while serving as an ophthalmologist in North Africa, 
Italy and India; additional stimulus was provided by experience gain­
ed during the past ten years in Africa and Australia, where large 
numbers of the population are affected. In this latter period, I 
attempted to assess the role of sulphones in its prevention (McLean ’),
and participated in a successful experiment to isolate the causative
4.organism (Mann, Greer, Ferret, and McLean *), but my main activities 
in the field of trachoma research have been concerned with its 
treatment and control.
Part 11 of this thesis gives a brief historical review 
of the subject, describes its pathology and bacteriology, discusses 
various enderaiological factors and outlines the differential diagnosis.
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In Part 111, trachoma in the Northern Territory of 
Australia is discussed, and details are given of the results of 
two forms of treatment in an isolated aboriginal community, of a 
combined form of therapy in a leprosarium where there was a high 
incidence of the disease, and of combined treatment in a white 
and part-coloured population. These results are analyzed statis­
tically in an attempt to arrive at a rational form of routine 
treatment.
Part IV discusses the importance of trachoma, 
reiterates the main points in diagnosis, summarizes the clinical 
effects, presents a scheme of treatment for routine use, and out­
lines methods for its control. ,
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HISTORICAL:
Probably the earliest reference to trachoma is to be 
found in the Ebers Papyrus, which dates back to about 1650 B.C. 
There the disease is mentioned, but is not described in detail. 
However, it is presumed that it originated in Egypt or the 
neighbouring countries of the Middle East. It was known to the 
ancient Greek physicians, and Hippocrates included it in the 
general term "ophthalmia"; in treatment, he advocated rubbing 
the palpebral conjunctiva with Milesian wool, which had been 
wound around a spindle of hard wood, until the blood ceased flow­
ing, and then cauterizing the treated surfaces. The Romans also 
knew the disease, and both Celsus and Galen suggested various 
forms of treatment. In the Middle Ages, Arab medical treatises 
dealt with its clinical appearance and treatment, but thereafter 
little appeared in the literature until the Napoleonic Wars, when 
large numbers of French and British troops, returning home from 
the Middle East, suffering from gross visual impairment or blind­
ness, focused attention once more on the disease. It is probable 
that, in the intervening period, trachoma had spread widely through­
out Asia and the countries bordering the Mediterranean, and it seems 
certain that it was conveyed to North and Central America by the 
colonizing Spaniards, but it seems to have remained largely unrecog­
nized at that time. The African tribes were probably infected by 
slave-raiding Arabs in the 18th. and 19th. centuries, and the 
Australian aborigines may have contracted it from visiting Malays 
and Indonesians. It also appears likely that the first white 
inhabitants of Australia, the convicts in the penal settlements, 
brought the disease with them from Britain. From the beginning of 
the 19th. Century, when it spread rapidly throughout Europe, it has 
come to be accepted as the most prevalent eye disease in the world.
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From the era of the ancient Egyptians until the 
fourth decade of this century, the commonest form of treatment 
was the vigorous application of crystalline copper sulphate to 
the conjunctiva of the eyelids and fornices, and this method is 
still used in some areas. As such treatment is exceedingly 
painful, and has to be prolonged, it is not surprising that 
there were numerous defaulters. In effect, a chemical cauter­
ization of the conjunctiva is performed and the formation of 
scar tissue is hastened; it is interesting to note that some of 
the severe cicatricial sequelae in old cases of trachoma may 
have been due to this. The advent of a new and less drastic form
5of treatment was heralded, in 1937, by the publication by Heinemann 
of the results of oral administration of sulphonamides, and the 
development,in the last twenty years, of antibiotic drugs has 
increased the number of therapeutic agents for use agaiftst the 
disease.
PATHOLOGY AND BACTERIOLOGY:
It has been established by means of experimental
inoculation of human subjects with (a) trachomatous material 
6
(Kapuscinski ), and (b) cultured virus (Collier, Duke-Elder and
2 4\Jones ; Mann, Greer, Ferret and McLean ), that the incubation
period of the disease is five to twelve days. In the experimental 
disease the onset is usually acute, with marked discotofort in the 
eyes, conjunctival injection, muco-purulent discharge, and enlarge­
ment of the pre-auricular ljhmph nodes, but in the naturally occurring 
form these signs are much less common and the onset in these cases is 
usually insidious.
MacCallan divided the course of the disease into four
main stages
stage 1, the stage of infiltration;
stage 11, the stage of active inflammation;
stage 111,the stage of scarring;
stage IV, the healed stage.
..... overleaf ..•••
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This classification is extremely useful for giving a general 
description of the disease, and will be adhered to in this 
section, but, as will be seen in Part 111 of this treatise,
1 prefer another classification for clinical purposes.
In stage 1, the earliest signs are seen in the 
upper fornix, the upper tarsal conjunctiva and the cornea; 
they are often so fine that at first they can only be seen with 
the bioraicroscope. Small bunches of dilated capillaries appear 
under the conjunctival epithelium, producing the appearance of 
bright red dots on the surface, and mingled with these are 
aggregations of lymphocytes in follicle formation, which are seen 
as yellowish spots. At the same time, the cornea in the upper 
limbal region shows epithelial oedema, and grey spots of lympho­
cytic infiltration situated in (and often under) the epithelium; 
this is referred to as "epithelial keratitis". Some authorities 
(Kimura, Obayashi, Ikawa and Kitamura ) are of the opinion that 
trachoma in its earliest stages may be present without these
corneal changes, but I have found them in every incipient case
9and I agree with Thygeson that, in their absence, trachoma cannot 
be diagnosed clinically at this stage.
In stage 11, the upper tarsal conjunctiva assumes a 
velvetty appearance, due to papillary hypertrophy. The hyper­
trophied papillae consist of conjunctival epithelium and subepi- 
thelial tissue infiltrated with lymphocytes and surrounding a 
central vascular core. Interspersed between the enlarged papillae 
are yellowish follicles, which by this time have increased consider 
ably in size; in some cases the papillary hypertrophy is so marked 
that it obscures the follicles, but in the majority the latter are
‘ -V ' - ' ; * . . .
prominently seen. The appearance of the upper and lower fornices 
is similar, but the changes may be less marked in the lower 
palpebral conjunctiva. In addition, follicles may sometimes be 
seen in the bulbar conjunctiva, plica semilunaris and caruncle.
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As the condition progresses, greyish elevations, like sago grains, 
may form in the upper tarsal conjunctiva, due to cystic degener­
ation of subconjunctival and tarsal glands which have become 
strangulated by lymphocytic infiltration; these may rupture, 
liberating a gelatinous material. Sometimes the whole upper tarsal 
conjunctiva has a brawny, swollen appearance. The upper tarsal 
plate, at this stage, becomes thickened by lymphocytic infiltration, 
and may produce a fora of ptosis, due to the resulting increase in 
weight and also, perhaps, to infiltration of Muller's muscle. In 
the cornea, further changes are seen; lymphocytic infiltration 
extends further into the cornea from the limbus, accompanied by 
extensions from the lirabal capillary loops, the combination of 
infiltration and vascularization being known as "trachomatous 
pannus". In the active stages of the disease, the infiltration 
extends further into the cornea than the vascularization. Follicles, 
similar to those in the conjunctiva, may sometimes be seen at the 
limbus, and these may rupture and subsequently become filled in by 
clear epithelium, giving rise to clear, oval areas in the pannus, 
the so-called "Herbert's pits". The pannus tends to spread down­
wards towards the pupillary area, but the rate of progress varies 
considerably, and many cases of uncomplicated trachoma show very 
little corneal involvement, although slit-lamp examination will 
always show some evidence of this.
In stage 111, the follicles in the conjunctiva become 
replaced by scar tissue. According to D u k e - E l d e r t h i s  is 
first seen as a white line, the cicatricial line of Arlt, running 
horizontally across the tarsus in the region where the ascending 
and descending conjunctival capillaries anastomose, but in my 
experience the first sign of scarring is often in the form of fine, 
stellate white lines situated in the upper third of the upper tarsal 
conjunctiva. In mild cases, particularly those which have been 
cured by early treatment, no further scarring occurs, and these
overleaf
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cases, if not subsequently re-infected, may, when re-examined 
after one year, show little or no sign of previous trachomatous 
infection; this has been noted independently by Professor Ida Mann 
(personal communication) and myself. In more severe cases, however, 
the scarring increases, replacing the follicles and hypertrophied 
papillae, so that eventually the whole upper tarsal surface may 
become smooth and white; these cicatricial changes are always 
much less marked in the lower lid. In the cornea, the infiltration 
slowly recedes, and at this stage the limbal capillary loops appear 
to extend further into the cornea than the infiltration. Finally, 
a thin grey layer .of scar tissue remains, in which can be seen 
attenuated or empty capillaries.
In stage IV, the trachomatous process is no longer 
active. Contraction of the scar tissue may, however, cause serious 
sequelae such as deformity of the upper tarsal plate, giving rise to 
entropion and trichiasis, which may in turn cause vascularization of 
the cornea and repeated corneal ulceration. The fornices tend to 
become obliterated, and symblepharon may form. Due to the involve­
ment of the conjunctival glands and their ducts in the cicatrization, 
the conjunctiva and the cornea may become xerotic. The scarring 
process may extend into the lacrimal sac, causing a chronic dacryoe- 
pystitis.
The duration of each stage of the disease, in the 
untreated case, varies enormously. Stage 1 may last from a few 
weeks to several months, while stage 11 may continue for 10 - 15 
years.: Stage H I  may then continue throughout life, although few
patients over 60 show signs of activity unless they have suffered 
a •fairly recent infection. In endemic areas, most patients become 
^infected in early childhood, and adults in stage 1 and stage 11 
'are mainly recent arrivals in these areas.
-g' SS ' r Discussion as to the causative ajgent of trachoma has 
been jprolific, and at times acrimonious, and the literature abounds
v ; ..... overleaf .....
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with claims to have isolated the responsible organism. Practically
every bacterium known to be found in the conjunctival sac has, at
one time or another, been accused of being the specific pathogen,
but no pure culture of any of these has ever produced the disease
on experimental inoculation. Only two of these claims are of
interest; Koch isolated, from trachoma cases in Egypt, a bacillus
12which was later (Weeks ) proved to be the cause of Koch-Weeks
13conjunctivitis, and Noguchi isolated B. granulosis (a variant of 
B. xerosis) from trachomatous North American Indians and with this 
produced a transient folliculosis in monkeys. Later attempts by 
other workers (Mayou*4 ; Wilson*5 ; Thygeson*5) to produce trachoma 
by inoculating human volanteers with his material failed to confirm 
his findings.
Bacteria having proved unproductive, other inicro- 
organisms were investigated, and in 1937 Cuenod and Nataf advanced 
the theory that a Rickettsia was responsible, suggesting that lice 
acted as vectors. They claimed that, by anal inoculation of lice, 
they could produce rapid multiplication of the organism, but this 
was never confirmed.
The first presumptive evidence that a virus might be
18the cause of trachoma was produced by Halberstaedter and Prowazek ,
who discovered cytoplasmic inclusion bodies in the conjunctival
epithelial cells of Javanese patients suffering from the disease.
As these inclusions typically formed a cap or mantle over one pole
of the nucleus of the cell, they named them "Chlamydozoa" and
postulated that they were a type of virus and the responsible agent
for trachoma. Numerous attempts were made to cultivate this virus
during the following four decades, but, owing to lack of suitable
media, these generally ended in failure. It is probable that the
first successful cultivation, in the yolk sacs of embryonated hens'
19eggs, was performed by Macchiavello , who claimed to have produced 
the disease in a human volunteer inoculated with a filtrate of the 
emulsified yolk sacs, but in the stress of the Second World War his 
work was largely overlooked and could not be confirmed. The
  overleaf .....
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credit for the first production in quantity of the virus by this 
method must go to the Chinese workers T'ang, Chang, Huang and 
Wang , who discovered that the addition of streptomycin to trach­
omatous material, before inoculation of the yolk sacs, inhibited 
the growth of bacterial contaminants without affecting the virus, 
whereas various other antibiotics prevented its multiplication. 
Collier, Duke—Elder and Jones repeated the Chinese experiments, 
and carried them a stage further by successfully inoculating a 
human volunteer. Since then,confirmation of these findings has 
come from various parts of the world, including Australia (Mann, 
Greer, Perret and McLean^), and it is now generally accepted that
this virus, or Chlamydozoon, is the causative agent of trachoma.
20It may exist in several different strains; Collier has reported
that two of the virus strains which he has isolated differ from
others in producing, in infected yolk sacs, compact collections of
virus particles surrounding large, single, multilocular or
multiple vacuoles, in addition to free elementary bodies, and he
suggests that these may indicate atypical forms of the virus.
The cultivation of the virus in all trachomatous areas may help
to elucidate this problem. Snyder, Page, Murray, Daggy, Bell,
21Nichols, Haddad, Hanna and McComb suggest that adenoviruses may 
play a part in producing the disease in some cases, but this has not 
yet been fully investigated.
At any stage of the disease, a secondary invasion of 
the conjunctivae by any of the common pathogenic bacteria may occur, 
and the combination of trachoma with repeated secondary conjunctivitis, 
if neglected or inadequately treated, greatly increases the severity 
of the disease. Indeed, it is now generally believed that the 
so-called "Egyptian11 or "classical" trachoma, with its recurrent 
corneal ulceration, extensive pannus and marked scarring,which may
result in virtual blindness, is due to this combination and not to
22 23infection with the trachoma virus alone (Ching ; Flynn ). This 
concept explains the great variation in the severity of trachoma
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which occurs in different parts of the world; in Egypt, for 
example, the dense fly population is constantly disseminating 
secondary infection, and the disease is seen in its most virulent 
and destructive form. Similarly, in the southern two-thirds of 
the Northern Territory of Australia, where the climate for nine 
months in the year is dry, hot and dusty, and where flies are 
numerous, trachoma is of the "classical" type, whereas in the 
northern one-third, which is less hot but more humid, and where 
flies are less of a problem, it is mostly of the uncomplicated 
variety, "trachome pur".
ENDEMI0L0GICAL FACTORS:
The various factors concerned in the endemiology of 
the condition may conveniently be discussed under the following 
headings:-




(a) Geographical and Racial.
There are few countries where trachoma is not 
endemic (Fig.l), but its incidence varies greatly from place to 
place. Egypt (its probably original habitat) and the adjoining 
countries show the highest overall incidence, but many other 
countries show an equally high incidence in certain regions, e.g. 
in parts of East, West, Central and South Africa, India, China, 
Russia and Japan. It is a common disease in Southern Italy, 
Yugoslavia, Czeehoslevakia, Greece, Spain, Central and South 
America, less common in the U.S.A. and Canada, and rare in the 
United Kingdom, New Zealand and the Scandinavian countries. In 
Australia, it is commoner than is generally recognized. It tends 
to be more severe in hot, dry, dusty, tropical and semi-tropical 





































ravages may be seer in any area.
There is no evidence of any racial immunity to the 
disease. For many years it was generally believed that the Bantu 
and Negro inhabitants of Africa were not affected, but this has 
long since been proved to be fallacious.
(b) Social.
Age and sex do not influence the liability to infection. 
In areas of high endemicity the disease usually begins in early child­
hood, and is often due to contact with infected parents.
It is frequently stated that trachoma is predominantly 
a disease of poor people, living in crowded and insanitary conditions. 
This is true as regards "Classical" or "Egyptian" trachoma, which is 
a combination of trachoma and repeated secondary infection, but not 
with regard to "trachome pur" or uncomplicated trachoma. Experience 
gathered from examination of prosperous and educated Negroes in West 
Africa, and of the white population in the Northern Territory of 
Australia, has convinced me that an adequate income and comfortable 
living conditions are not necessarily effective barriers to the 
spread of the infection. Strict personal hygiene is an effective 
deterrent, but unfortunately this does not always coincide with 
improved economic status.
(c) Infective.
The infective nature of the disease has never been 
seriously doubted. It is known to be contagious, and contact with 
an infected person or fomites may be the sole means of spread, but 
this has by no means been proved. There is at least the possibility 
that the infection may also be fly-borne, dust-borne, or disseminated 
by droplet infection, and up to the present little has been done to 
investigate this. The disease is certainly more prevalent where 
flies abound, and in dusty areas; the lacrimal passages have been 
described as undergoing trachomatous changes (Charamis ), and it is 
possible that the virus may enter the nasal passages and be
..... overleaf .....
disseminated from there. Now that successful cultivation of the 
virus is possible, these problems should be elucidated.
The infectivity of trachoma appears to vary consider­
ably. This may be due to some strains of the virus being more 
virulent than others, or it may be connected with the presence or 
absence of other conjunctival pathogens; cultivation and comparison 
of the characteristics of the virus from different regions should do 
much to solve this. My own investigations in the Northern Territory 
of Australia indicate that there is little difference in the in­
cidence of the disease in the various areas there, but that the 
severity of the condition varies considerably due to the presence or 
absence of secondary infection.
An attack of trachoma does not render a patient immune 
to subsequent re-infection, and this causes one of the great diffi­
culties in the control of the disease. This lack of immunity may 
be due to the fact that trachoma is a localised diseese, confined 
mainly to the conjunctival sac and the cornea, so that antigen may 
not enter the systemic circulation in sufficient quantity to stimulate 
the production of antibodies, and the possibility remains that an 
immunizing vaccine may eventually be produced from cultivated virus,
(d) Associated Diseases.
From time to time, various systemic diseases, such as 
malaria or tuberculosis, have been noted in association with the 
onset of trachoma, but there is no evidence to show that this assoc­
iation is other than coincidental. Local eye conditions, however, 
and in particular acute conjunctivitis, undoubtedly influence the 
course of the disease. Trachoma diminishes the resistance of the 
conjunctiva to invasion by other organisms, and, should secondary 
bacterial or viral infection occur, the symptoms increase markedly 
in.severity. An acute muco—purulent or purulent conjunctivitis 
developes, and corneal ulceration is a frequent complication; such
overleaf
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an ulcer, if untreated, may perforate the cornea, leading to 
adherent leucoma, anterior staphyloma or phthisis bulbi. pannus 
tends to extend further into the cornea during a superadded 
infection. Papillary hypertrophy increases to such an extent that 
it sometimes complete masks the follicles, and in such cases, if 
seen for the first time, the primary condition may be missed if the 
cornea is not examined.
I have frequently observed, in trachomatous native 
children in Africa and the Northern Territory of Australia, a 
profuse, muco-purulent rhinitis. Whether this is connected or not 
with the trachoma process I do not know, but it would be interesting 
to see if the virus could be cultivated from the secretion or from 
scrapings of the nasal mucosa.
SYMPTOMATOLOGY:
The symptoms of uncomplicated trachoma vary considerably, 
but in the majority of cases there is surprisingly little discomfort.
In stage 1, it is unusual for the patient to complain of 
any symptoms at all; the bulbar conjunctiva is rarely injected, and 
it is easy to overlook the disease unless the upper eyelids are evert­
ed and examined for follicles, and the corneae inspected carefully 
(with a slit lamp if necessary) for epithelial keratitis. These signs 
may be fairly obvious in one eye and almost non-existent in the other, 
but it is exceedingly doubtful if trachoma ever occurs uni-ocularly in 
the naturally-occurring form of the disease, although it can undoubt­
edly be produced experimentally. Enlargement of the pre-auricular
lymph node is rarely found in the natural disease, but is common in
25the experimental form. Tsutsui found this lymphadenopathy in cases 
having an acute onset with severe pain in the eyes, oedema of the eye­
lids, marked injection of the bulbar conjunctiva and profuse muco­
purulent discharge. These cases are rare, and I have had no personal 
experience of them, but I have seen an identical picture in
overleaf
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experimentally produced, trachoma* The acute signs subside in two 
or three weeks, and further progress follows the pattern of those 
with an insidious onset.
The symptoms of stage 11 and stage 111 consist mainly 
of a gritty sensation in the eyes, with very slight mucoid discharge. 
There may be a slight injection of the bulbar conjunctiva, but this 
is never marked in uncomplicated cases. Indeed, it is remarkable how 
rarely, even in florid cases with marked papillary hypertrophy and 
numerous follicles, the patient complains of much discomfort.
Rupture of limbal follicles may be followed by corneal ulceration, in 
which case the complaint is of severe pain, lacrimation and photo­
phobia, and superficial circumcorneal injection is evident. Very 
occasionally, epithelial keratitis affects the central portion of the 
cornea, causing some diminution of vision.
Jn stage IV, symptoms are due to the results of cicat­
rization, such as entropion, trichiasis, corneal opacities and xero­
phthalmia.
It cannot be emphasized too strongly that uncomplicated 
trachoma is not a severe disease leading inevitably to impaired 
vision or blindness. The danger lies in the trachomatous patient 
being exposed to repeated, uncontrolled attacks of secondary conjunc­
tivitis; these produce the complications and sequelae which we are 
accustomed to describe as "classical" or "Egyptian" trachoma. It is 
important to remember this when considering the prognosis, as the 
probability is that, if such infection can be prevented or cured, the 
patient will retain good vision throughout life. This does not mean, 
however, that treatment should be directed solely to secondary 
infection when it occurs, and that the trachomatous process itself 
should be ignored. So long as trachoma is active, the liability to 
secondary infection remains great, and the only way to prevent this 
is to eradicate the primary condition.
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DIAGNOSIS:
The Expert Committee on Trachoma of the World Health
26Organization in its "Second Report" , recommended certain criteria 
of diagnosis, and these have been almost universally accepted.
They are
1. follicles in the upper tarsal conjunctiva,
2 . epithelial keratitis,
3. pannus,
4. scarring of the upper tarsal conjunctiva.
The presence of two or more of these signs is considered to be 
diagnostic of trachoma. In an established case the diagnosis is 
usually easy, and the main difficulty arises in mild or early cases. 
The presence of follicles in the upper tarsal conjunctiva should 
always arouse suspicion, and a thorough examination of the cornea 
for epithelial keratitis or pannus at the upper limbus should be 
carried out; if either of these is present, trachoma may be diag­
nosed with confidence.






(e) raolluseum contagiosum conjunctivitis,
(f) vernal conjunctivitis.
(a) Conjunctival Folliculosis
Conjunctival follicles, affecting mainly the lower 
fornix, are commonly found in children. The upper tarsal con­
junctiva is unaffected, and there is never any corneal involve­
ment. The condition gradually resolves, without scarring.
27 1,4According to Duke-Elder , it is merely a local expression of
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the adenoid ectivity so frequently found in youth.
In adults, folliculosis may occur due to the instill­
ation of drugs, such as atropine or eserine. The lower fornix
is mainly involved, the cornea remains clear, and there is often 
an associated moist eczema of the skin of the eyelids.
(b) Inclusion Conjunctivitis.
This disease is interesting in that it produces, in 
conjunctival epithelial cells, inclusion bodies which are morpho­
logically similar to those of the trachoma virus, and the respons—
2Sible organism has recently(Jones, Collier and Smith ) been
cultivated b3r a similar method. The symptoms, which are acute,
consist of irritation in the eyes, photophobia and mucopurulent
discharge. The eyelids may be slightly swollen. A pre-auricular
lymphadenopathy appears in two or three days, and about the seventh
day follicles begin to become obvious. These are always more
numerous in the fornices and the lower palpebral conjunctiva than
in the upper tarsal region, and are never found in the bulbar
conjunctiva. There are no corneal changes. The acute symptoms
subside in .about four weeks, and although the follicles may
remain for many months they eventually resolve, leaving no
scarring. The disease is most commonly found in new-born infants,
who are infected at birth from the mother’s genito-urinary tract 
29(Lindner ), but may occur in older children and adults in 
epidemic form, often after swimming in communal baths.
The exact relationship of the virus of inclusion con­
junctivitis to that of trachoma has not yet been decided. It 
seems probable, in view of the fact that the disease causes no 
corneal involvement or cicatrization, that the two viruses are 
distinct, although closely related.
overleaf
8
with claims to have isolated the responsible organism. Practically
every bacterium known to be found in the conjunctival sac has, at
one time or another, been accused of being the specific pathogen,
but no pure culture of any of these has ever produced the disease
on experimental inoculation. Only two of these claims are of
interest; Koch isolated, from trachoma cases in Egypt, a bacillus
12which was later (Weeks ) proved to be the cause of Koch-Weeks
13conjunctivitis, and Noguchi isolated B. granulosis (a variant of 
B. xerosis) from trachomatous North American Indians and with this
produced a transient folliculosis in monkeys. Later attempts by
14 15 16other workers (Mayou ; Wilson ; Thygeson ) to produce trachoma
by inoculating human volunteers with Iiis material failed to confirm
his findings.
Bacteria having proved unproductive, other micro-
* 17organisms were investigated, and in 1937 Cuenod and Nataf advanced 
the theory that a Rickettsia was responsible, suggesting that lice 
acted as vectors. They claimed that, by anal inoculation of lice, 
they could produce rapid multiplication of the organism, but this 
was never confirmed.
The first presumptive evidence that a virus might be
18the cause of trachoma was produced by Ilalberstaedter and Prowazek ,
who discovered cytoplasmic inclusion bodies in the conjunctival
epithelial cells of Javanese patients suffering from the disease.
As these inclusions typically formed a caĵ  or mantle over one pole
of the nucleus of the cell, they named them "Chlamydozoa" and
postulated that they were a type of virus and the responsible agent
for trachoma. Numerous attempts were made to cultivate this virus
during the following four decades, but, owing to lack of suitable
media, these generally ended in failure. It is probable that the
first successful cultivation, in the yolk sacs of embryonated hens1
19eggs, was performed by Macchiavello , who claimed to have produced 
the disease in a human volunteer inoculated with a filtrate of the 
emulsified yolk sacs, but in the stress of the Second World War his 
work was largely overlooked and could not be confirmed. The
  overleaf .....
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eyelids they may give rise to a chronic follicular conjunctiv­
itis. Usually the cornea remains clear, but in rare cases
32pannus, similar to that of trachoma, developes (Thygeson ).
In these cases, however, the characteristic lesions on the lid 
margins clinch the diagnosis.
(f) Vernal Conjunctivitis.
This is a common disease in tropical climates, and in 
the summer months in temperate zones. It is probably an allergic 
phenomenon, but its exact aetiology is unknown. Two forms occur, 
the palpebral and the limbal, and these may co-exist. In the 
palpebral form, the upper tarsal conjunctiva shows milky, flat- 
topped papillae which, while typical, may be mistaken by inex­
perienced observers for trachomatous follicles; similar, but
less marked changes are found in the lower lid, but the fornices
are never involved. In the limbal form, a gelatinous swelling 
is seen in the bulbar conjunctiva at the limbus, and this may 
completely surround the cornea. Very rarely a type of pannus, 
more gelatinous in appearance than that of trachoma, is found.
It is not uncommon to find vernal conjunctivitis and trachoma 
co-existing, and in such cases it is usually the limbal form of
the former which is present.
There are various laboratory aids to the diagnosis of 
trachoma, but some of these, involving complement fixation tests 
or the cultivation of the virus in the yolk sacs of embryonated 
hen eggs, are not suitable for areas where the facilities are 
limited. The examination of scrapings of the upper tarsal con­
junctival epithelium for the presence of Halberstaedter-Prowazek 
inclusion bodies may, however, be readily undertaken. The 
material for this procedure is collected by everting the upper 
eyelid and rubbing the exposed conjunctival surface firmly with 
a platinum loop or metal spatula; I have found local anaesthesia
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unnecessary for this, even in very young children. Smears of 
this material are then made on clean microscope slides, allowed 
to dry in air for five minutes, and stained with Lugolfs iodine 
or Giemsa's solution.
The Lugol's iodine method, as described by Gilkes,
33Smith and Sowa , stains deep orange-brown the carbohydrate 
matrix in which the inclusion bodies lie, and this shows in 
affected epithelial cells, when examined with the oi1-^immersion 
objective of the microscope, as dot-like particles in the cyto­
plasm. Unaffected cells stain golden-yellow* This method 
enables inclusion bodies to be identified rapidly, anil for 
confirmation the slide may then be washed with xylol or toluol, 
decolorized and fixed with 95$ methyl mmL alcohol, and stained 
with Giemsa’s solution.
The method of staining with Giemsa's solution, which I
34prefer, is the slow one described by Mackie and McCartney •
With this, the inclusion bodies show typically as purplish-red 
dots arranged in a crescentic fashion around one pole of the cell 
nucleus (Fig.2)5 the purplish-red colour is due to the presence 
in the inclusions of both initial bodies, which stain dark blue, 
and elementary bodies, which stain pink. The initia.|L bodies may 
vary in size from 0.5 micron to 1.5 microns, and are usually 
round in shape, while the elementary bodies are about 0.25 micron 
and may be round or oval. The inclusions may vary considerably 
in appearance, in some instances consisting of a few dots at one 
end of any epithelial cell, and in others completely filling the 
cytoplasm (Fig.3)5 if composed entirely of ?elementary bodies 
they appear red in colour* They must be distinguished from 
extrusions from the cell nucleus, which have a much more solid 
appearance, and from pigment granules, which are generally 
irregular in shape and stain black.
overleaf
l«c*</ifOM SowV
Fig% 2. Conjunctival scraping. Epithelial cell in centre of 
field shows crescentic Halberstaedter-provazek inclusion body 
forming cap 011 nucleus. Stained Gienisa. x 1000.
Fig. 3. Conjunctival scraping. Halberstaedter—Prowazek 
inclusion body fills one end of cell in centre of field. 
Stained Giemsa. x 1000.
Inclusion bodies are not invariably present in trachoma, 
but I have found thenij often after prolonged examination of the 
smear, in about 30$ of untreated cases with active follicles.
The only other condition in which similar inclusions occur is 
inclusion conjunctivitis, but the absence of corneal changes 
differentiates this from trachoma.
TREATMENT:
The sulphonamides and the antibiotics are now the most 
commonly used drugs in the treatment of trachoma. They are known to 
exert a specific action on viruses of the psittacosis-lymphogranuloma 
group, to which the trachoma virus belongs; this action is thought 
to be viristatic rather than viricidal, which may explain why they 
are not always completely effective. The sulphonamides work best 
when administered orally, while the antibiotics are usually applied 
topically in the form of drops, ointments or oily suspensions.
Not all of the antibiotics, however, are effective. Streptomycin, 
as was shown by T ’ang and his colleagues'*', does not inhibit the
growth of the virus, and although penicillin, used either locally
35 36 37(Bietti ) or parenterally (Gilkes, Smith and Sowa ; Smith ), has
its advocates, I have not been impressed by its usefulness; cases
which I have treated with local applications have remained virtually
unchanged, while those receiving intramuscular injections have shown
some temporary improvement but have invariably relapsed. Collier,
38Duke-Elder and Jones had a similar experience when treating a case 
of experimentally-produced trachoma.
Combined treatment with oral sulphonamides and topical 
antibiotics is often used, the former being given for two weeks and 
the latter instilled for eight. If, however, there is a previous 
history of sensitivity to sulphonamides, these are contraindicated, 
and, even where there is not, a close watch must be kept for drug 
reactions. While many cases are undoubtedly healed after a single 
course, resistant cases occur, and in these treatment must be pro­
longed; there is a possibility, which requires to be investigated,
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that some strains of the virus are more resistant than others.
If prolonged treatment is required, I prefer to continue this 
with local antibiotics, as the danger of systemic disturbances
from these is negligible• *
Corneal ulceration is a frequent complication in , 
cases which have become secondarily infected; it is not caused 
by the trachoma virus itself. If present, atropine instillations 
should be added to the other treatment until the cornea has healed.
The sequelae of the disease, such as entropion and
trichiasis, are treated surgically, usually by a wedge resection 
of the tarsus.
CRITERIA OF E U R E :
Trachoma may be considered cured when all follicles 
have disappeared, the conjunctiva is smooth, and the pannus vessels 
have become empty and attenuated. In most cases some conjunctival 
scarring will remain, and this may be considerable in extent, but 
some early cases may resolve completely under treatment, the con- 
junctivae and corneae later presenting an entirely normal appearance. 
In general, if treatment is commenced before scar tissue has begun to 
form, the final result will be a network of fine, stellate scars in 
the upper tarsal conjunctiva and a thin, crescentic grey opacity, 
containing empty blood vessels when viewed with the slit lamp, in 
the cornea at the upper limbus. The cornea near the upper limbus 
may show Herbert1s pits, but these are not diagnostic of healed 
trachoma since they may be found in cases showing active follicles 
and pannus. Cases which show some scarring before treatment usually 
show more marked scarring when healed.
The absence of Halberstaedter-Prowazek inclusion bodies 
from conjunctival scrapings cannot be regarded as one of the criteria 
of cure, since they are not always found in active cases, and when
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present they tend to disappear within a week of commencement of 
treatment. The finding of these, however, in apparently healed 
cases, is of significance, as this indicates either that the con­
dition is merely dormant or that re-infection has occurred. In 
the latter connection, it must be remembered that trachoma produces 
little or no natural immunity, and that in endemic areas re-infection 
is a constant threat.
The topical application of cortisone has been advocated 
39by Nataf, Maurin and Dupland as a test of cure. They fouiid that
some cases of apparently healed trachoma showed signs of fresh
S'activity after several instillations of the corticoteroid, and they 
concluded that in these cases the condition had merely become 
dormant. I have had similar experiences, and believe this to be a 
valuable test.
PROPHYLAXIS:
Strict personal hygiene is probably the best prophy­
lactic againts trachoma. The hands should be washed immediately 
after Contact with a known or susj)ected case, and the communal use 
of towels should be prohibited. In areas where flies are prevalent, 
steps should be taken to eradicate them. Cases of acute conjunctiv­
itis should receive prompt and adequate treatment. These points 
should be emphasized in lectures to the public in regions where the 
disease is rife.
The cultivation of the virus has stimulated research 
into the possibility of producing a vaccine which could be used 
prophylactically and therapeutically(Grayston, Wang, Woolridge,
Yang and Johnston^), and if this can be achieved a great advance 











TRACHOMA IN THE NORTHERN TERRITORY OF AUSTRALIA:
The Northern Territory of Australia ‘(Fig.4) lies" 
between latitudes 11°S. arid 26°S., and longitudes 129°E. Although 
it is situated mainly within the Tropic of Capricorn, the climatic 
conditions in its northern one-third differ considerably from those 
in the southern two-thirds. The north has a maritime tropical 
climate, with a temperature range from 95°F. to 60°F., and an aver­
age relative humidity of 80$ for nine months of the year; in the 
central and southern regions the temperature ranges from 115°F. to 
30°F., and the relative humidity rarely exceeds 30$. Dust storms 
are rare in the north, but are frequent in the southern two-thirds.
In the areas of high humidity flies are scarce, but they are a 
constant scourge in the drier areas. These climatic factors are of 
importance when considering the type of trachoma encountered in the 
Territory.
The population consists of about 36,000 persons, of 
whom about 18,000 are white, 3,000 part-coloured and 15,000 aboriginal. 
The white and part-coloured are mainly concentrated in four centres on 
the Stuart Highway, which extends for almost 1,000 miles from Darwin, 
on the coast in the north, to Alice Springs in the south. Darwin 
(population 10,000) is the administrative capital of the Territory; 
Katherine (1,000) lies 220 miles south of this, while Tennant Creek 
(1,000) and Alice Springs (4,000) are respectively 642 and 957 miles 
south of Darwin. The aborigines live mainly in mission stations and 
Welfare settlements, about half of these being in the north and the 
riest in the southern two-thirds.
For many years, trachoma has been known to exist 
amongst the aborigines of the Territory, but no serious attempt was 
made to estimate its extent, or severity, until the Second World War, 
when white troops were moved into the area and the 109th. Australia^
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General Hospital was established at Alice Springs. Y/hen aborigines 
from the surrounding area began, in 1942, to attend this hospital 
for treatment, it was found that the incidence of eye disease amongst 
them was high, and that practically all of them exhibited the signs 
and symptoms of ''classical1’ trachoma - in passing it may be mentioned■' 5 • :.'
that most Australian ophthalmologists were at that time, and still
are, unaware that the disease can exist in an uncomplicated form -
and that this might constitute a threat to the health of the troops
in the area. As a result, surveys of the native population were
undertaken, at first by the Australia Military Forces and later by
the Commonwealth Department of Health. The results of these have
23been well summarized by the Rev. Frank Flynn , a Roman Catholic
priest who is also a trained ophthalmologist, who carried out many
41of these surveys. Schneider , to a lesser and more limited extent, 
contributed corroborative evidence. These surveys showed that 
trachoma was present in the aborigines throughout the Territory, and 
that, in most instances, over 50$ of the native population were 
affected, There was a marked difference, however, in the severity 
of the disease in the northern region when compared with the centre 
and south. In the north it was mainly mild and uncomplicated, 
while in the other two areas the "classical” variety was common.
During this time, little attention was paid to the 
possibility of the disease existing in the white population of the 
Territory. It had been known to exist in "classical” form, through­
out Australia (particularly in Queensland and the northern part of 
South Australia) at the end of the last and the beginning of this 
century, but as, with the passing of the years, less and less cases of 
this type were seen, it came to be assumed "that it was no longer
present in those of European descent. An interesting article, pub-
42lished in the Medical Journal of Australia by Rodger and Priestley 
in 1915, gives an excellent description of uncomplicated trachoma in 
school children in western Queensland, but this seems to have been 
ignored by the Australian ophthalmologists of that time. By the
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beginning of the Second World War, it was generally accepted that 
white Australians did not suffer from trachoma, and all cases of 
entropion and trichiasis were ascribed to other causes. Neverthe­
less, many in the rural areas continued to suffer from '’granular 
conjunctivitis11, and often received copper sulphate treatment from 
their local general practitioners.
In 1954, Mann, while investigating eye disease in the 
Kimberley region for the Western Australian Government, discovered 
that not only aborigines but white school children were affected 
(Mann43) , and in subsequent surveys (Mann4 ^*45) she showed that 
similar conditions existed in other regions of that State. Mean­
while medical officers of the Northern Territory Medical Service were 
beginning.to report cases in the white population of the Territory, 
and this, combined with the fact that large numbers of the1 aborigines 
there were now known to be infected, resulted in the decision of the 
Commonwealth Department of Health to appoint an ophthalmologist to, 
investigate and treat the eye disease in this region. In July, 1959,
I became the first to hold this appointment.
The Northern Territory is a vast area of over 500,000 
square miles, and as the sole practibing1ophthalmologist I found it 
impossible, in the two years which I spent there, either to cover the 
whole region fully or to confine my activities solely to the invest­
igation of trachoma. Nevertheless, from my base in Darwin I was 
able to visit all the larger centres and many of the mission stations 
and Welfare settlements, and to examine a large cross-section of the 
total population* -From this, I was able to estimate that 50$ had 
trachoma5 85$ of this occurred in the aborigines and particoloured,
and 15$ in the whites. T h e r e  was no difference in the incidence of
23the disease in the various areas, but I confirmed Flynn’s findings 
that in the north it was mainly "traehome pur”, wherqas in.the centre 
and south secondary bacterial conjunctivitis was a common complication. 
Bacteriological investigations showed that, in the complicated cases, 
the commonest secondary invaders were the staphylococcus aureus and
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and the bacillus of Koch-Weeks, while occasionally Morax-Axenfeld 
bacillus was involved* Complicated trachoma was rarely found in 
the white population in any of the areas.
CLINICAL CLASSIFICATION OF TRACHOMA:
The MacCallan classification possesses the disadvan­
tage that it is; a pathological one, not always easily applicable
to the clinical appearance of the disease* In an attempt to over- 
44come this, ;Mann introducedherclinicalclassification,in which 
the following stage s w e  re described!- t. /
Stage A, active and infectious trachoma; ' ,
stage B, healed trachoma with good vision;
stage C, healed trachoma with impaired vision; ?
stage D, healed trachoma with loss of all useful vision*
Later, she modified this to include stage A-B, a transition stage
in which the disease is still active but there is also evidence of 
healing*
In my investigations of trachqma in; the Northern 
Territory I found that the Mann classification w^h, useful as a 
basis, but did not adequately cover the progress'of the active stage 
of the diseases Accordingly,I modified stage A, dividing it into 
four sub-divisions i- "
A* 1, <active trachoma with no scarring (Fig«5).,
A*2, active trachoma with minimal scarfing (jj’i&.h)
A.3, active trachoma with marked scurr£|h»|r^Fi
A*4* active trachoma with marked >%car£i$g ̂ 3̂ 1̂ defectivev v̂»vVv' * * M
vision due to corneal comp 1 fcatibns* ‘V  ,V,• <p ' -v r > ‘i v ̂* r
Stage A—B was discarded, and stages B(Fig*8), C and D were retained 
as in the original classification* In this form, the Mann class­
ification is now used throughout the Northern Territory*
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Fig. 5 . Trachoma, stage A.I. Follicles in upper tarsal 
conjunctiva. Pannus at upper limbus.
Fig. 6. Trachoma, stage A.2. Follicles in subtarsal sulcus.
Slight scarring of upper tarsal conjunctiva.
31.
Fig. 7. Trachoma, stage A.3. Marked scarring and active 
follicles upper tarsal conjunctiva.
Fig. 8. Trachoma, stage B. Marked scarring of upper tarsal 
conjunctiva. No follicles.
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TREATMENT OF TRACHOMA IN THE NORTHERN TERRITORY?
A routine course of treatment, based on the recommend-?-
a'tions of the Expert Committee on Trachoma of the World Health Grgan- 
. . 26ization , was already in operation in some parts of the Territory on 
my arrival. This consisted of two weeks of sulphadiazine orally 
three times daily, combined with the topical application of chlor- 
tetracyeline ointment twice daily for eight weeks. I found that, 
when patients conscientiously carried out this treatment, the results 
were good, 75^ being cured after a single course; however, many 
patients forgot or neglected to take the sulphonamide regularly, 
while others were unable to continue the chlortetracyc1ine instill­
ations for more than one or two weeks because of irritation of the eyes. 
The latter difficulty was overcome by substituting chloramphenicol 
ointment, which proved to be well tolerated, for chlortetracycline, 
but the problem of adequate sulphonamide administration remained.
About this time, two new products, a long-acting sulphonamide, sulpha- 
methoxypyridazine, and an antibiotic, tetracycline in sesame oil, were 
made available to us for clinical trial, and experiments were planned 
to attempt to ascertain:-
(a) how the results of treatment with sulphamethoxypyridazine 
compared with those obtained with tetracycline in oil;
(b) how small a dosage of sulphamethoxypyridazine would be 
effective;
(c) whether twice weekly treatment with sulphamethoxypyridazine 
would be sufficient;
(d) whether treatment with either of these products alone was 
'r ' ' as effective as combined treatment with1 sulphonamides and 
'rc antibiotics.
The areas chosen for these experiments were the Roper River Missiop, 
.Ejast Arm Leprosarium and Darwin. t, , ; ,
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This mission station is situated in the northern region 
of the Northern Territory 300 miles south-east of Darwin and about 
50 miles west of the Gulf of Carpentaria, its geographical position' 
being 14.5 S. and 134.5°E. It is administered and staffed by the 
Church Missionary Society, and caters for a population of about 250 
aborigines. The community is an isolated one, and as a result there 
is less fluctuation of population than in other aboriginal settlements; 
for this reason, and also because it was suspected that trachoma in 
this area, although of high incidence, was mainly of the uncomplicated 
variety, it was considered suitable for treatment studies.
As a preliminary, shortly before the supplies of sulpha­
methoxypyridazine and tetracycline arrived, the entire population of 
the mission was examined for evidence of trachoma. At the time of 
the examination 243 persons were in residence, and of these 220 (90.5$) 
were found to be affected. Table 1 shows the incidence of the di.seaje 
according to the modified Mann classification.
TABLE 1.
INCIDENCE OF TRACHOMA AT ROPER RIVER MISSION.
A.l A.2 A.3 A.4 B. C. D.
106 41 58 2 11 2 0
From this, it will be seen that, of the 220 persons affected,
207 (94$) had active trachoma, and only 13 (6$) could be considered 
inactive. However, there were none who could be classified as blind 
from the disease, and only 4 (1.9$) had defective vision.
The distribution of the various categories according to 
age groups is given in Table 2, and this shows, as one would expect, 




DISTRIBUTION OF TRACHOMA, IN AGE GROUPS.
A.l A.2 A.3 A.4 B. C. D. Totals.
0-5 years 50 3 1 0 0 0 0 54
6-10 34 16 2 0 0 0 0 52
11-15 8 6 1 0 0 0 0 15
16-20 10 5 8 0 0 0 0 23
21-30 4 9 31 0 4 1 0 49
31-40 0 2 7 1 4 0 0 14
41-50 0 0 1 0 0 0 0 1
Over 50 0 0 7 1 3 1 0 12
TOTALS 106 41 58 2 11 2 0 220
Cultures from conjunctival swabs, taken at random 
from the population, were either negative or yielded growth only 
of coagulase-negative staphylococcus albus, indicating that second­
ary conjunctivitis was not a problem in the area, and that the 
disease as seen there could be regarded as "trachome pur". The 
clinical pattern of the disease tended to confirm this, as corneal 
ulceration was noted in only two cases (classified as A.4), and 
pannus rarely extended more than 3 mm. from the limbus. The two 
healed cases (stage C) with defective vision gave histories of 
previous trauma, which may have accounted for their corneal opacities. 
The eleven cases which were healed with good vision (stage B) showed 
fairly extensive scarring of the upper tarsal conjunctivae, but 
minimal cicatrization of the corneae at the upper limbus, little or 
no entropion and no symblepharon.
When treatment was commenced, 168 of the active cases 
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were treated as fojlowst-,., , .
group 1, asliie: tablets ©rally once daily
for 15 days;
group 13, sulphamethoxypyridazine tablets orally once daily 
  ----- for. 8 days;. ..  .....
group^111,sulphamethoxypyridazine tablets orally twice weekly 
for 4^ weeks;
gr??P ^Yi tetracycline in oil drops twice daily in each
"■ . “ eye for"'8' weeks •
The dosage scale used ,fn this experiment is illustrated in Table 3.
. ; < Of the 4£,patients in each group, 37 attended
regularly for treatment in group 1, 35 in group 11, 36 in group 111
and 34 in group TV, so that in all 142 completed the prescribed 
course** When examined two months after the conclusion of treatment, 
82(58^). were found to he-cured according to the criteria described- 
in Part 11. No further treatment was instituted at this time,, but 
the patients were re-examined four months later, in order ta conform 
with the World Health Organization recommendation that six;.months 
should e1 apse before final assessment• At this examinati.on the 
situation Remained unchanged, the 82 cured patients appearing^ 
completely healed, while the remaining 60 still showed evidence of
activity; this sup|3orts the view which I hold, that two months is
a sufficient time in whloh to assess the effects of treatment.
The ‘ results of treatment of the various grottps are 
shown in Table...4* — .. .— .... .
2v -zCJj'r '.TABLE 4.
 ̂ -
~ • • ~ - ”"‘''T3ESTTpTS'"DF“ TREATMENT IN EACH G R O W
k '
Group 1 . k> 
(37 Pats.)
Group*11* 






CURED 20 (54^) 18 (51^) 22 (61$) 22 (64$) 82
HOT CURED 17 (46^) 17 (49$) 14 (39$) ‘ ■ 12 i m r bo
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Table 5 shows the effectiveness of treatment of 
the various categories in e&?b group.
" TABLE " 5.  ̂ '
EFFECTIVENESS OF TREATH^T OF VARIOUS CATEGORIES;  ̂"1
CATEGORY GROUP lvj GROUP 11. GROUP 111. j GROUP IV.
V r’i, CUREDAt 1 • 8 (4Y$) 8 (36?) 11 (61?) 13 (62*)
NOT mffiED 9 (sm 14(64?) ~ 7 (30%) ' '8 (38*)
, o CUREDA# c* # 5 (38?) 4 (67?) 6 (54.5?) 4 (57*)
NOT CURP> , 8 (62?) *. (33?) 5 (45.5?) 3 (43*)
' „ CURED A • o • 7 (100?) 4 (80%) 5 (71?) 5 (83*)
NOT CUR$D 0 , I (2p?) 2 (29?) ... 1 ( ^ )
5\ ^ CURED A.4. 0 '•■■''■ '• 2 (100%) 0 !i:i v*0.; >.'V̂
NOT CURED 0 o - 0 ! 0 5 -
The results were subjected to statistical analysis
2using the X test for independence* to ascertain if there was a 
significant difference betveen the various forms of sulphamethoxy- 
pyridazine treatment, or between the sulphamethdxy^p idazine ahd 
the tetracycline treatment. Tables 6 and 7 illustrate this-.-—
'■’t a b l e ' 6.’ ‘ '
TEST OF SIGNIFICANCE OF DIFFERENCE OF VARIOUS FORMS 
OF StlPHAMTHOXYPYEIDA2IKE T R E X T M d s T T ~
1 1 '■
GROUP 1. GROUP 11. GROUP 111. TOTAL
CURED 20*(20.5)* 18 (19.4)* 22 (20)* 60
NOT CURED 17 (*16.5)* 17 (15.6)* 14 (16)* 48
-  ̂ ' )  ' W1 M . 1; !  ' i  U v  ^ y,  j . . 1, ; . <x,  1 \ i  /' .
37 ~ 35 36 108
^Figures in parentheses indicate expected numbers. 
X^ s 0.69. For two degrees of freedom, this is not significant.




TEST OF SIGNIFICANCE OF DIFFERENCE 
OF SULPHAMETHOXYPYRIDAZINE AND TETRACYCLINE TREATMENTS.
SULPHAMETHOXYPYRIDAZINE TETRACYCLINE TOTAL
CURED 60(62.4) 22 (19.6) 82
NOT CURED 48 (45.6) 12 (14.4) 60
168 34 142
X a 0.90. For one degree of freedom, this is not
significant.
The effectiveness of treatment of the various cate­
gories (excluding category A.4, in which the numbers involved were 
too small) was similarly analyzed, with the result shown in Table 8 .
TABLE 8 .
TEST OF SIGNIFICANCE OF EFFECTIVENESS OF TREATMENT 
OF VARIOUS CATEGORIES.
A . 1 • A.2. A.3. TOTAL
CURED 40 (44.6) 19 (21.1) 21 (14.3) 80
NOT CURED 38 (33.4) 18 &5.9) 4 (10.7) 60
78 37 25 140
oX * 8.92. For two degrees of freedom, this is 
definitely significant.
t, ' ' ‘ ' ' ' ' '
As Table 9 shows, there is no significant difference
v . . . • J" '
in the results of treatment of categories A*l* and A.2••— , ,
\ V’ ,, i * ' * i * *
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TABLE 9.
TEST OF SIGNIFICANCE OF DIFFERENCE OF EFFECTIVENESS 
OF TREATMENT OF CATEGORIES A.I. AND A.2.
A.l. A.2. TOTAL
CURED 40 (40) 19 (19) 59
; NOT CURED 38 (38) 18 (18) 56
78 21 115
X m 0 j i.e. there is no significant difference. 
A.l and A.2 may therefore be considered as one category, and if 
this category is compared with A.3, a significant difference is 
found, as shown in Table 10:—
TABLE 10.
TEST OF SIGNIFICANCE OF DIFFERENCE OF EFFECTIVENESS 
OF TREATMENT OF CATEGORIES A.l + A.2 and A.3. ; -
A.l + A.2 A.3 TOTAL
CURED 59 (65.7) 21 (14.3) 80
NOT CURED 56 (49.3) 4 (10.7) 60
115 25 140
2X at 8.92. For one degree of freedom, this is
significant.
No toxic reactions were observed in any of the patients 
treated with the sulphonamide. Several of those who received tetra­
cycline drops complained of intense smarting of the eyes after each 
instillation, but this did not prevent them from continuing treatment. 
Aborigines appear to have a greater tolerance to pain than Europeans 




The conclusions drawn from this experiment were?—
1. There was no significant difference between the results
of treatment with oral sulphamethoxypyridazine and with
topical tetracycline. Approximately 60$ of cases of
uncomplicated trachoma may be expected to be cured after
a limited course of treatment with either of these drugs;
2 . within the dosage range used, the smaller doses of sulph-
methoxypyridazine were as effective as the larger ones;
3. twice weekly treatment with sulphamethoxypyridazine for
4^ weeks was as effective as daily treatment for 15 or 8 days
4. treatment was more effective in the later stages of the
disease.
East Arm Leprosarium.
3In a previously published paper (McLean ) I described 
the incidence of trachoma in this closed community, which is situated 
12 miles south-west of Darwin, and pointed out that the sulphones, 
although chemically similar to the sulphonamides, had no effect on 
its prevention, but the treatment of the affected patients was not 
discussed. n -
Of the 172 patients residing in the Leprosarium,
152 (88.4/6) showed signs of active or healed trachoma; of these 
40,9.(71.7$) were active, and 43 (28.3$) healed. The numbers in the 
various categories are shown in Table 11.
TABLE 11.
CATEGORIES OF TRACHOMATOUS PATIENTS 
AT EAST ARM LEPROSARIUM.
A.l A.2 A.3 A.4 B. C. D.
30 35 38 6 34 8 1
overleaf
As would be expected in a medical institution, the incidence of 
secondary conjunctivitis was negligible, and the active disease 
existed in the uncomplicated form.
. . . .  '
The 109 active patients were treated with oral sulpha—
diazine and topical chlortetracycline. The dosage of the sulphon­
amide was adjusted to the age of the patient, and was given three 
times daily for two weeks5 chlortetracycline was instilled twice 
daily in each eye from the commencement of s u 1 p h adiazine therapy, 
and was continued for eight weeks. No toxic reactions to the 
sulphonamide were observed, and all patients completed the chlor— 
tetracycline treatment although a few complained of conjunctival 
irritation. After two months, the effects of treatment were 
assessed, and 84 (77$) were found to be cured, while 25 (23$) 
required further treatment. The results in the various categories 
are shown in Table 12:-
TABLE 12.
RESULTS OF COMBINED SULPHADIAZINE AND ClfLORTETRACYCLINE THERAPY















No significant difference in the results of treatment 
was found between categories A.l and A.2, or between categories A.3 
and A.4, but, as shown in Table 13, there was a significant differ­
ence between A.l + A.2 and A.3 A.4.
ascr: ‘ 'J i I
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TABLE 13.
TEST OF SIGNIFICANCE OF DIFFERENCE OF EFFECTIVENESS 
OF TREATMENT IN CATEGORIES A.l + A.2 AND A.3 + A.4.
A.l + A.2 A.3 + A.4 TOTAL
CURED 44 (50.1) 40 (33.9) 84
NOT CURED 21 (14.9) 4 (10.1) 25
65 44 109
X =s 8.00. For one degree of freedom, this is
significant.
When the results were compared with those obtained 
at Roper River Mission, a significant difference, in favour of the 
combined treatment, was found. This is shown in Table 14s-
TABLE 14.
TEST OF SIGNIFICANCE OF DIFFERENCE OF EFFECTIVENESS OF TREATMENT 
AT ROPER RIVER MISSION AND EAST ARM LEPROSARIUM.
ROPER RIVER EAST ARM TOTAL
CURED 82 (93.9) 84 (72.1) 166
NOT CURED 60 (48.1) 25 (36.9) 85
142 109 251
2X =s 10.25. For one degree of freedom, this is 
highly significant.
It was therefore concluded that combined therapy 
with sulphonamides and antibiotics was more effective than treat­
ment with either of these groups of drugs alone. Once again it 
was noted that the later stages of the disease responded better to
♦
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1-4 .
treatment thanithe earlier stages* • ' i obtains
V.'J - r:; < : r -?,d C h I O'!" La t; f '■ V 0 i UK'- "uh^T t';.'-iV ?t
DARWIN:
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Having arrived at the conclusion that combined 
treatment was more effective, itreinained to be determined whether 
there was a significant difference between combined treatment with 
sulphadiaziiie and chlortetracyc line and clpipbined t r e A i m e ^ fwith 
sulphamethoxypyridazine and tetracycline.
100 white and part-coloured patients in Darwin were 
selected for .this part of the study, 46 being in category A .lj 
29 in category A.2 and 25 in category A.3. It,may be notAd here 
that the majority of the white residents in Darwin are civil 
servants* or their f ami lies who have -resided there for onlyivoor*- 
three years, and so would not be expected to show signs of the- 
later stages of trachoma; all whites taking part in this experi­
ment were in categories A.l and A.2. The part-coloured patients 
were distributed through each category and constituted the whole of 
category A.3. r; c . uuV'i ■ ■
Sulphamethoxypyridazine, in a dosage adjustedf to 
the age of the patient, was given once daily for two weeks, and' 
tetracycline in oil suspension was instilled twice daily'in each 
eye• Unfortunately, after two or three days, all patients com­
plained bitterly of intense conjunctival irritation due; to the * r c 5 
tetracycline suspension, and chloramphenicol ointment.had to be 
substituted for this and continued for eight weeks. The results 
of this combined therapy are given in Table 15:- s #
TABLE 15, e r 'LI: ■ ary
RESULTS OF COMBINED SULPHAMETH OXTDlTftl DAZI NE
? AND CHLORAMPHENICOL THERAPY " K  t- «
-■ A • 1 • A.2. A.3. f TOTAL 1
CURED 36 ( 7 8 3 ) 23 (79'.#) } 23 (90.8$) t " si
NOT CURED 16 (2 1 3 ) 6 (20.7$) 2 (9.2$) »8
i -- |P--- — '
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When these are compared with the results obtained 
with combined sulphadiazine and chlortetracycline therapy at 
East Arm Leprosarium, no significant difference is found (Table 16).
TABLE 16.
TEST OF SIGNIFICANCE OF DIFFERENCE OF EFFECTIVENESS 
OF TREATMENT WITH SULPHADIAZINE 4 Chlortetracycline 






CURED 84 (86.6) 82 (79.4) 166
NOT CURED 25 (22.4) 18 (20.6) 43
109 100 209
significant.
X = 0.80. For one degree of freedom, this is not
From these three experiments, it was concluded that:-
1 . combined therapy with oral sulphonamides and topical
antibiotics is more effective in trachoma than treat­
ment with either of these alone; they appear to act 
synergistically when used together;
2 . sulphamethoxypyridazine is as effective as sulphadiazine,
and has the advantage that a smaller dosage is 
required;
3 . the total dosage of sulphonamides commonly given in the
treatment of trachoma is greater than is necessary;
4 p of the three topical antibiotics used, chloramphenicol 
produced the least conjunctival irritation;
5. after a single course of oral sulphonamides 4 topical
antibiotics, approximately 25^ of patients will ,
require further treatment;
  overleaf .....
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6 . the response to treatment is greater in the later than
than in the: earlier stages of the .disease f
7. if signs of activity are still present two moiiths after
the cessation of treatment, further treatment will
be required.  ̂ n
ADDITIONAL OBSERVATIONS: n
The patients who were not cured by these courses of 
treatment received further therapy. In order to avoid the risks 
of skin and systemic reactions or blood dyscrasias due to sulphon- 
amides, topical antibiotics alone were used for these, and were 
continued until all signs of activity had disappeared. In most 
cases an additional two to three months of this treatment was 
sufficient, but in a few it had to be prolonged for about One year. 
Chloramphenicol was the most commonly used antibiotic, but in the 
most resistant cases chlortetracycline and oxytetracycline were 
also used. Occasionally, when treatment was switched from one 
antibiotic to another, rapid healing occurred, but no one antibiotic 
was consistently more effective than the others.
In this series of experiments, none of the-■ patients 
receiving sulphonamides gave a history of sensitivity to these drops,
and no toxic reactions occurred. This, however, was unusual; in 
the Territory as a whole, 0.5^ of trachomatous patients stated that 
they were sensitive to sulphbnamides and were treated solely with 
antibiotics, while a further 1$ had to stop sulphonamide treatment 
!because of signs of toxicity. For the most part these were mild, 
consisting of transient skin rashes, headache or nausea, but one 
while child of 8 years of age developed erythema multiforme bullosum 
awhile taking sulphamethoxypyridazine. The specialist physician 
who attended to her was not convinced that the drug was responsible, 
but I think that it was the probable cause. Fortunately with 
antibiotic and corticosteroid therapy she recovered completely.
..... overleaf .....
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In the central and southern regions of the Territory, 
trachoma was complicated by secondary infection in 95$ of the 
aboriginal cases, 50j$ of the part— coloured, and* less that 2$ of 
the white. Corneal opacities, due to extensive pannus or resulting 
from corneal ulceration or trichiasis, caused defective vision in 
10$ of the aboriginal patients and 3$ of the part-coloureds, but the 
incidence of blindness was less than 1$. The living conditions of 
the aborigines are similar throughout the Territory and climatic 
factors appear to be responsible for the prevalence of the compli­
cated form in the centre and south. In the north, the high humidity 
restricts fly-breeding and the dissemination of infection by dust, 
while exactly the opposite is found in the other two regions.
Combined therapy was used routinely, except when sulphon­
amides were contraindicated, in the central and southern regions.
When secondary infection was present, the antibiotic was instilled 
four-hourly until this had resolved, and atropine was used where there 
was any corneal ulceration. Where treatment could be closely super­
vised the results after a single course were comparable to those 
obtained in the north, but in many of the Welfare settlements, due to 
a shortage of nursing staff, this could not be achieved, and in these 
areas we were fortunate if a 60$ cure rate resulted. On the average, 
about 50$ were cured.
37In the northern region, following Smith's report of an 
apparent cure of trachoma with intramuscular penicillin, it was 
decided to assess this form of treatment on a small number of patients.
1,000,000 Units of penicillin G were given intramuscularly to ten 
patients daily for five days; one week later, there was some apparent 
improvement in that the papillary hypertrophy was less, but within a 
month all had reverted to their condition previous to treatment. As 
I had previously, in West Africa, treated trachomatous patients with 
topical penicillin, with complete lack of success, it was concluded 
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5 ' 1 DISCUSSION a n d  c o n c l u s i o n s
IMPORTANCE OF TRACHOMA:
It is undoubtedly true that trachoma is the most ! (
prevalent eye disease in the world. Its severity, however, varies 
considerably, and evidence is accumulating that this is due to the 
presence or absence of secondary infection. Where the latter is 
negligible, or can be rapidly and effectively controlled, the* 
primary condition is relatively innocuous and the danger of its 
producing blindness or even defective vision is slight, but there 
are large areas where, owing to lack of medical facilities, low 
standards of personal hygiene and inadequate sanitary control, the 
problem of "classical’1 trachoma remains.
The disease is present throughout the Northern 
Territory of Australia and its incidence is high. That it is 
mainly of the uncomplicated variety in the northern region, while 
in the centre and south secondary infection is common, appears to 
be due to climatic factors, especially the degree of humidity.
There is, however, no difference in the incidence of the primary 
disease in the various areas. Defective vision resulting from the 
condition is negligible in the northern region, and is likely to 
decrease in incidence in the other regions, due to active treatment 
campaigns. If these are continued, the disease should, within a 
few years, cease to be a problem of significance in the Territory.
DIAGNOSIS:
Follicles in the upper tarsal conjunctiva, epithelial 
keratitis, pannus and scarring of the upper tarsal conjunctiva are 
the major signs of trachoma, and the presence of two or more of
..... overleaf .....
these is diagnostic of the disease* Difficulty in diagnosis is 
most likely to arise in mild or early cases, which must be differ­
entiated from such conditions as conjunctival folliculosis,
AncIusi°n conjunctivitis, pharyngoconjunctival fever, epidemic 
keratoconjunctivitis, molluscum contagiosum conjunctivitis and 
vernal conjunctivitis; the points of difference of these from 
trachoma have already been discussed. In areas of high endemicity, 
it is advisable to treat all doubtful cases as trachomatous.
CLINICAL EFFECTS:
In the majority of cases, the clinical effects of 
uncomplicated trachoma are slight. During the active stages, the 
patient usually complains of some discomfort, mainly in the form of 
a gritty sensation in the eyes, and there may be a slight mucoid or 
watery discharge from the conjunctival sac, but the condition may 
be practically symptomless. It is rare for epithelial keratitis or 
pannus to extend so far into the cornea as to cause diminution of 
vision. In the healed stage, if scarring, is extensive, some degree 
of entropion will be present, and this may be severe enough to cause 
trichiasis and resultant corneal ulceration and opacification, but 
it is rare to find this in cases which have not been secondarily 
infected.
In complicated cases, one or.more attacks of acute 
conjunctivitis, of bacterial origin, occur. This may cause the 
patient to seek medical attention for the first time, and in such 
cases papillary hypertrophy due to the secondary infection may 
obscure the follicles in the upper tarsal conjunctiva, with the 
result that the primary condition may be overlooked if the cornea 
is not examined, for epithelial keratitis or pannus. Corneal ulcer- 
ation is a common complication of these attacks, and pannus increases 
considerably; from these, severe and permanent visual impairment 
may result. Repeated attacks of conjunctivitis increase the
overleaf
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liability to extensive conjunctival scarring, entropion, symblepharon 
and xerophthalmia.
TREATMENT:
Oral sulphonamides and topical antibiotics have super­
ceded other forms of therapy for trachoma. The experiments 
described in Part 111 indicate that combined treatment with fehesb 
is more effective than treatment with either of these groups of' 
drugs alone, and that with such treatment about 75$ of cases may be 
cured after a single course. The remainder will require more 
prolonged treatment, and for this, in order to avoid the risk of 
sulphonaraide reactions or blood dyscrasias, antibiotics in topical 
form should be used.
Sulphadiazine appears to be as effective as sulpha- 
methoxypyridazine, but the latter has the distinct advantage; that a 
smaller dosage is required, and for this reason should be the 
sulphonamide of choice. As regards the antibiotics, it haq been 
my experience in the Northern Territory that chloramphenicol is 
best tolerated by the patients, particularly when treatment has to 
be prolonged. I have not found penicillin to be of any val^e in 
treatment.
As a routine form of treatment I would suggest the 
oral administration of sulphamethoxypyridazine twice weekly for 
four weeks, combined with the twice daily instillation of oculentum 
chloramphenicol for eight weeks, provided that there is no history 
o£ sulphonamide sensitivity and that the patient can be observed 
frequently for signs of drug reaction. If, two months later, the 
condition is still active, chloramphenicol should be continued for 
a further eight weeks, after which, if still not healed, chlor— 
tetracycline or oxytetracycline should be tried. My impression is
overleaf
tIiese resistant cases are caused by a different strain of the 
virus, but I have no proof of this. In any case, some of them 
require treatment for about ohe year before they are cured.
When secondary infection is present, the antibiotic should 
be instilled four hourly until this has subsided, and then Continued 
twice daily for the remainder,of the eight week period; iftherS'is 
any corneal ulceration, gtt. atropine 1$ should be instilled three 
times daily until this has healed.
Where there is a history of sensitivity to sulphbnamidds, 
sulphamethoxypyridazine must never be used. These cases sliould be 
treated solely with local antibiotics.
CONTROL:   f •
Ideally, in order to eradicate the infection in areas where 
it is known to exist, everyone should be examined for trachoma1', but
, t r , ■ V ' , i •’ i ; •: # ’this is rarely a practical possibility. However, as the disease is 
most active in the early years of life, every effort should* ^e made 
to examine all pre-school and school children at least once every 
six months, and all cases should be treated immediately. The parents 
of affected children should also be examined and treated if necessary. 
In this way, the incidence of the disease can be greatly reduced.
I also consider it advisable that all treated cases should be 
examined once a year for evidence of re— infection.
Health authorities should initiate campaigns against flies 
where these are prevalent. In addition, by means of lectures, they 
should instruct the public in personal hygiene and should stress the 




. fl. Uncomplicated trachoma is not a severe disease, and, if 
properly treated, should not result in visual 
impairment.
2. The combination of oral sulphonamides and topical anti­
biotics is the most effective method of treatment.
3. Sulphamethoxypyridazine, because of the lower dosage
required, is the sulphonamide of choice.
4. Chloramphenicol, when applied topically, has the advantage
over other antibiotics that it produces less local
3 reaction.
I am indebted to the Director-General, Commonwealth 
Department, of Health, Australia, for permission to publish the 
results of the experiments which I conducted in the Northern 
Territory, and to the medical officers and nursing staff of the 
Northern Territory Medical Services for their co-operation,
I am also grateful to Mr. Town Hopkins, of Lederle Division*,
Cyanamid Co. of Australia, for the generous supply of sulphamethoxy-
’ ipyriduzine, ated tetracycline in nil used in these experiments.
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